A large multistate cohort study of more than 40,000 pregnant women and their nonpregnant peers found no link between COVID-19 vaccination during pregnancy and preterm or small-for-gestational-age births.
United States flu activity jumped again the week ending Dec 18, with eight states reporting high or very high activity and the first two pediatric flu deaths reported for the season, the US Centers for Disease Control and Prevention (CDC) said today in its regular update.
A new study presented at an American Society of Health-System Pharmacists (ASHP) meeting finds that influenza vaccination rates are low for people without a regular healthcare provider, at just 20.5%, as well as among minority groups.
Vaccine coverage among American adults with a regular provider was 44.5%, according to the research, which was presented yesterday at the society's midyear conference.
A UK study yesterday in The Lancet finds that flu and COVID-19 vaccines can be safely co-administered.
Use of a rapid diagnostic test in patients with bloodstream infections (BSIs) was associated with shorter times to optimal antibiotic therapy and antibiotic de-escalation, researchers reported yesterday in Clinical Infectious Diseases.
Hospitalized COVID-19 patients who were treated with remdesivir within 2 days of admission had lower mortality rates than their matched cohort, according to a study today in Clinical Infectious Diseases. The observational cohort consisted of US adults hospitalized with COVID-19 from August to November 2020; 28,855 received remdesivir and 16,887 did not.
The 10-year plan starts today and gives recommendations for a range of scientific disciplines to better address seasonal flu and prepare for the next flu pandemic.
An analysis of US health insurance data found that post-discharge prophylactic antibiotics are commonly prescribed after mastectomy, but provide only a small reduction in surgical-site infections (SSIs), researchers reported today in Infection Control & Hospital Epidemiology.
People who received the flu vaccine prior to having COVID-19 had less risk of sepsis, stroke, deep vein thrombosis (DVT), and disease requiring emergency or intensive care, according to a study presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) this year.
The global prevalence of vancomycin-resistant Staphylococcus aureus (VRSA) has more than tripled in the past two decades, according to a systematic review and meta-analysis yesterday in Antimicrobial Resistance & Infection Control.
